vs
安捷伦科技(A)与PACS Group, Inc.(PACS)财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是PACS Group, Inc.的1.3倍($1.8B vs $1.4B)。安捷伦科技净利率更高(17.0% vs 4.4%,领先12.6%)。PACS Group, Inc.同比增速更快(18.4% vs 7.0%)。过去两年PACS Group, Inc.的营收复合增速更高(20.5% vs 6.9%)
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商,旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器,服务全球各领域客户。
A vs PACS — 直观对比
营收规模更大
A
是对方的1.3倍
$1.4B
营收增速更快
PACS
高出11.4%
7.0%
净利率更高
A
高出12.6%
4.4%
两年增速更快
PACS
近两年复合增速
6.9%
损益表 — Q1 2026 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $1.8B | $1.4B |
| 净利润 | $305.0M | $59.7M |
| 毛利率 | 52.6% | — |
| 营业利润率 | 19.6% | 7.0% |
| 净利率 | 17.0% | 4.4% |
| 营收同比 | 7.0% | 18.4% |
| 净利润同比 | -4.1% | 3022.5% |
| 每股收益(稀释后) | $1.07 | $0.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
A
PACS
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.7B | $1.1B | ||
| Q3 24 | $1.6B | $1.0B | ||
| Q2 24 | $1.6B | $981.4M |
净利润
A
PACS
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $59.7M | ||
| Q3 25 | $336.0M | $52.4M | ||
| Q2 25 | $215.0M | $51.0M | ||
| Q1 25 | $318.0M | $28.5M | ||
| Q4 24 | $351.0M | $1.9M | ||
| Q3 24 | $282.0M | $15.6M | ||
| Q2 24 | $308.0M | $-10.9M |
毛利率
A
PACS
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | 17.1% | ||
| Q2 24 | 54.4% | 22.3% |
营业利润率
A
PACS
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 7.0% | ||
| Q3 25 | 20.7% | 6.4% | ||
| Q2 25 | 18.0% | 6.2% | ||
| Q1 25 | 22.4% | 3.8% | ||
| Q4 24 | 24.0% | 1.7% | ||
| Q3 24 | 21.1% | 2.2% | ||
| Q2 24 | 23.1% | 0.1% |
净利率
A
PACS
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 4.4% | ||
| Q3 25 | 19.3% | 3.9% | ||
| Q2 25 | 12.9% | 3.9% | ||
| Q1 25 | 18.9% | 2.2% | ||
| Q4 24 | 20.6% | 0.2% | ||
| Q3 24 | 17.9% | 1.5% | ||
| Q2 24 | 19.6% | -1.1% |
每股收益(稀释后)
A
PACS
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $0.42 | ||
| Q3 25 | $1.18 | $0.32 | ||
| Q2 25 | $0.75 | $0.31 | ||
| Q1 25 | $1.11 | $0.17 | ||
| Q4 24 | $1.23 | $-0.03 | ||
| Q3 24 | $0.97 | $0.10 | ||
| Q2 24 | $1.05 | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $197.0M |
| 总债务越低越好 | $3.0B | $353.2M |
| 股东权益账面价值 | $6.9B | $946.8M |
| 总资产 | $12.8B | $5.6B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.37× |
8季度趋势,按日历期对齐
现金及短期投资
A
PACS
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $197.0M | ||
| Q3 25 | $1.5B | $355.7M | ||
| Q2 25 | $1.5B | $294.2M | ||
| Q1 25 | $1.5B | $287.5M | ||
| Q4 24 | $1.3B | $157.7M | ||
| Q3 24 | $1.8B | $49.5M | ||
| Q2 24 | $1.7B | $73.4M |
总债务
A
PACS
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $353.2M | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | $411.9M | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
股东权益
A
PACS
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $946.8M | ||
| Q3 25 | $6.4B | $871.3M | ||
| Q2 25 | $6.1B | $806.8M | ||
| Q1 25 | $6.0B | $750.2M | ||
| Q4 24 | $5.9B | $709.6M | ||
| Q3 24 | $5.9B | $660.0M | ||
| Q2 24 | $6.2B | $572.1M |
总资产
A
PACS
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $5.6B | ||
| Q3 25 | $12.2B | $5.6B | ||
| Q2 25 | $12.2B | $5.5B | ||
| Q1 25 | $11.9B | $5.5B | ||
| Q4 24 | $11.8B | $5.2B | ||
| Q3 24 | $11.0B | $4.5B | ||
| Q2 24 | $10.9B | $3.9B |
负债/权益比
A
PACS
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 0.37× | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | 0.58× | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $268.0M | $-3.4M |
| 自由现金流经营现金流 - 资本支出 | $175.0M | — |
| 自由现金流率自由现金流/营收 | 9.7% | — |
| 资本支出强度资本支出/营收 | 5.2% | — |
| 现金转化率经营现金流/净利润 | 0.88× | -0.06× |
| 过去12个月自由现金流最近4个季度 | $993.0M | — |
8季度趋势,按日历期对齐
经营现金流
A
PACS
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $-3.4M | ||
| Q3 25 | $362.0M | $204.8M | ||
| Q2 25 | $221.0M | $52.6M | ||
| Q1 25 | $431.0M | $150.2M | ||
| Q4 24 | $481.0M | $64.6M | ||
| Q3 24 | $452.0M | $209.2M | ||
| Q2 24 | $333.0M | $34.8M |
自由现金流
A
PACS
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | — | ||
| Q3 25 | $259.0M | — | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | $334.0M | — | ||
| Q4 24 | $388.0M | — | ||
| Q3 24 | $360.0M | — | ||
| Q2 24 | $230.0M | — |
自由现金流率
A
PACS
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 19.9% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 14.6% | — |
资本支出强度
A
PACS
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 6.5% | — |
现金转化率
A
PACS
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | -0.06× | ||
| Q3 25 | 1.08× | 3.91× | ||
| Q2 25 | 1.03× | 1.03× | ||
| Q1 25 | 1.36× | 5.28× | ||
| Q4 24 | 1.37× | 33.78× | ||
| Q3 24 | 1.60× | 13.39× | ||
| Q2 24 | 1.08× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
PACS
暂无分部数据